Amaç: Kliniğimizde iki yıl boyunca transkateter yolla atriyal septal defekt kapatılması işlemi yapılan hastalarla ilgili klinik deneyimlerimizin paylaşılması ve sonuçlarının değerlendirilmesi amaçlandı. Gereç ve yöntemler: Çalışmaya, sekundum atriyal septal defekt nedeniyle transkateter yolla kapatma işlemi uygulanan, ortalama yaşı 8 olan 5 yaş 3 ay-16 yaş 24 hasta 16 kız, 8 erkek , retrospektif olarak dahil edildi. Bulgular: Kapatma işlemi hastaların 22’sinde % 92 başarılı bir şekilde gerçekleştirildi ve takiplerde cihaz erezyonu, aritmi, tromboz veya rezidüel şant gibi herhangi bir komplikasyon gelişmedi. Bir hastada işlem sırasında cihaz embolizasyonu oldu, cerrahiye verilen hastada cihaz çıkartıldı ve defekt başarılı bir şekilde kapatıldı. İki hastada % 8 işlem başarısız oldu. Atriyal septal defekt kapatma cihazı olarak Amplatzer septal okluder kullanıldı. Kapatma işlemi yapılan hastalara altı ay süre ile antiagregan dozda asetilsalisilik asit tedavisi verildi. Sonuç: Sekundum atriyal septal defektlerin perkütan yolla tıkayıcı cihazlarla kapatılması etkili, güvenli ve başarı oranı yüksek, komplikasyon gelişme ihtimali düşük bir tedavi şeklidir. Son yıllarda cerrahi tedavinin yerini almıştır
Allen HD, Driscoll DJ, Shaddy RE, et al. Heart disease in ınfants,
children and adolescent. Prieto LR, Latson LA. Atrial septal defects. 8th ed. Lippincott Williams Wilkins, 2013;672-90.
Chan KC, Godman MJ, Walsh K, et al. Transcatheter closure of
atrial septal defect and interatrial communications with a new self
expanding nitinol double disc device (Amplatzer septal occluder):
multicentre UK experience. Heart 1999;82:300-6.
Pastorek JS, Allen HD, Davis JT. Current outcomes of surgical closure of secundum atrial septal defect. Am J Cardiol 1994;74:75-7.
Çeliker A. Konjenital kalp hastalıklarında girişimsel tanı ve tedavi.
Çeliker A. Atriyal septal defektlerin transkateter yöntemlerle kapatılması. Erkem Tıbbi Yayıncılık, 2008:210-23.
Yared K, Baggish AL, Solis J, et al. Echocardiographic assessment
of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging 2009;2:141-9.
Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the
Amplatzer septal occluder. J Am Coll Cardiol 2005;45:1213-8.
Levi DS, Moore JW. Embolization and retrieval of the Amplatzer
septal occluder. Catheter Cardiovasc Interv 2004;61:543-7.
Kaya MG, Özdoğru İ, Baykan A, et al. Transcatheter closure of
secundum atrial septal defects using the Amplatzer septal occluder
in adult patients: our first clinical experiences Türk Kardiyol Dern
Arş 2008;36:287-93.
Harles E, Mullins ME. Transcatheter atrial septal defect occlusion.
In Mullins CE, ed. Cardiac catheterization in congenital heart disease: Pediatric and adult. Oxford: Wiley-Blackwell, 2006:728-79.
Year 2014,
Volume: 24 Issue: 3, 90 - 92, 01.01.2014
Objectives: This study was aimed to evaluate our clinical experience and investigate results of transcatheter closure of atrial sep- tal defect patients in our clinic during the past two years. Material and methods: Retrospectively 24 patients 16 female, 8 male undergoing transcatheter atrial septal defect closure procedure with mean age 8 range, 5 years and 3 months-16 years old were included. Results: Transcatheter atrial septal defect closure procedure was successfully performed in 22 patients 92% without any complication like device erosion, arrhythmia, thrombosis or residual shunt during follow-up. Transcatheter atrial septal defect closure procedure failed in two patients 8% . Amplatzer septal occluder device was used as atrial septal defect closure device. For six months, acetylsalicylic acid treatment in antiaggregant dose was given to the patients who underwent atrial septal defect closure procedure. Conclusion: Percutaneous closure of secundum atrial septal defects with occlusive devices is safe and effective procedure with a high success rate and less complications. This procedure started to replace surgical treatment of atrial septal defects in last decades
Allen HD, Driscoll DJ, Shaddy RE, et al. Heart disease in ınfants,
children and adolescent. Prieto LR, Latson LA. Atrial septal defects. 8th ed. Lippincott Williams Wilkins, 2013;672-90.
Chan KC, Godman MJ, Walsh K, et al. Transcatheter closure of
atrial septal defect and interatrial communications with a new self
expanding nitinol double disc device (Amplatzer septal occluder):
multicentre UK experience. Heart 1999;82:300-6.
Pastorek JS, Allen HD, Davis JT. Current outcomes of surgical closure of secundum atrial septal defect. Am J Cardiol 1994;74:75-7.
Çeliker A. Konjenital kalp hastalıklarında girişimsel tanı ve tedavi.
Çeliker A. Atriyal septal defektlerin transkateter yöntemlerle kapatılması. Erkem Tıbbi Yayıncılık, 2008:210-23.
Yared K, Baggish AL, Solis J, et al. Echocardiographic assessment
of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ Cardiovasc Imaging 2009;2:141-9.
Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J. Cardiac perforation after device closure of atrial septal defects with the
Amplatzer septal occluder. J Am Coll Cardiol 2005;45:1213-8.
Levi DS, Moore JW. Embolization and retrieval of the Amplatzer
septal occluder. Catheter Cardiovasc Interv 2004;61:543-7.
Kaya MG, Özdoğru İ, Baykan A, et al. Transcatheter closure of
secundum atrial septal defects using the Amplatzer septal occluder
in adult patients: our first clinical experiences Türk Kardiyol Dern
Arş 2008;36:287-93.
Harles E, Mullins ME. Transcatheter atrial septal defect occlusion.
In Mullins CE, ed. Cardiac catheterization in congenital heart disease: Pediatric and adult. Oxford: Wiley-Blackwell, 2006:728-79.